H.R. 2855 · 116th Congress
To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.
- Stage
- In committee
- Sponsor
- Steve King
- Introduced
- 2019-05-20
- Latest action
- 2019-05-21 · Referred to the Subcommittee on Health.